Rite Aid promo offers free generic script

Share this article:

Chain pharmacy Rite Aid is offering one free 30-day generic prescription to customers in Georgia, South Carolina and North Carolina, in exchange for enrollment in the drug store's Rite Aid Rx Savings Card.

Patients already signed up for the card are also eligible for a free script, from a list of more than 300 commonly prescribed generic drugs. The offer is available through June 30, 2009.

“The continuing economic crisis has caused many Americans to lose their jobs and their health insurance,” said Bill Wolfe, group vice president, Rite Aid, in a statement. “It is critical for patients with chronic diseases to stay on their therapy, and generic pharmaceuticals represent a cost effective way to do that.”

The Rite Aid Rx Savings card is free, and does not require any membership fees, according to the statement.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...